Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,13 USD | +1,43 % | -2,74 % | -69,22 % |
Resumen de negocios
Número de empleados: 16
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ilya Rachman
CEO | Chief Executive Officer | 52 | 01/01/12 |
Gabriel Morris
DFI | Director of Finance/CFO | 38 | 01/03/21 |
Graham Ross
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/06/21 |
Nandan Oza
PRN | Corporate Officer/Principal | 61 | 01/05/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jane Buchan
BRD | Director/Board Member | 60 | 01/07/21 |
Jason Hsu
BRD | Director/Board Member | 50 | 01/01/13 |
Magda Marquet
BRD | Director/Board Member | 65 | 01/06/21 |
Carey Ng
BRD | Director/Board Member | 45 | 01/11/19 |
Helen Adams
BRD | Director/Board Member | 65 | 01/06/21 |
Ilya Rachman
CEO | Chief Executive Officer | 52 | 01/01/12 |
Gabriel Morris
DFI | Director of Finance/CFO | 38 | 01/03/21 |
Director/Board Member | 39 | 22/08/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 26 468 783 | 14 277 691 ( 53,94 %) | 72 363 ( 0,2734 %) | 53,94 % |
Información de la empresa
Immix Biopharma, Inc.
11400 West Olympic Boulevard Suite 200
90064, Los Angeles
+
http://www.immixbio.comVentas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-69,22 % | 56,22 M | |
-4,66 % | 86,13 mil M | |
+1,32 % | 39,82 mil M | |
-19,27 % | 30,42 mil M | |
+57,86 % | 25,23 mil M | |
-16,09 % | 15,35 mil M | |
-9,14 % | 11,95 mil M | |
-17,69 % | 11,6 mil M | |
-43,00 % | 11,51 mil M | |
+5,24 % | 8710,47 M |
- Bolsa de valores
- Acciones
- Acción IMMX
- Empresa Immix Biopharma, Inc.